Mylan

So now the price for the EpiPen, the life saving immediate response for severe allergic reactions, has been raised about 400%, from about $100 to $500. 
This will make it prohibitively expensive for some people. 
The pharmaceutical company, Mylan, is the exclusive manufacturer of this project, ie, Myland has a monopoly.
Mylan recently dramatically increased the salaries of their top executives.
The EpiPen is mostly (not exclusively) used by children.

Thankfully, there will be multiple hearings in Congress - because this price increase affects so many, many families.  Unlike the Shkreli price increase that affects a relatively small group of people, however, essential that drug is.

Here's the thing.  Without the EpiPen, the cost of treatment for allergic attack will increase astronomically - the ambulance, the emergency room, possibly significant hospital stay.  If the victim of an allergic attack, without the EpiPen, even survives.

Can you say tin ear?  A widely used essential drug, in a Presidential election year.  How stupid, as well as insensitive, can a company be.